⚡️💉🇺🇸 NEW - Kennedy: "HHS has determined that mRNA technology poses more risk than benefits" in humans for respiratory viruses.

"The data show these [mRNA] vaccines fail to protect effectively against upper respiratory infections like COVID and flu."

That’s why BARDA has begun the process of terminating these 22 contracts.